Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

A Randomised, Double-Blind, Placebo-Controlled, Crossover Efficacy and Safety Evaluation of 8-Week Treatment Periods of Two Doses [5 Mcg (2 Actuations of 2.5 Mcg) and 10 Mcg (2 Actuations of 5 Mcg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler® as Add-on Therapy in Patients With Severe Persistent Asthma.

Projekt: Typer af projekter

Vis graf over relationer
StatusAfsluttet
Periode01/08/200601/09/2007
URLhttp://clinicaltrials.gov/ct/show/NCT00365560?order=46
Forskningsprogram<ingen navn>

ID: 32558328